157 related articles for article (PubMed ID: 38088062)
1. Comparison of bleeding and thrombotic outcomes in veno-venous extracorporeal membrane oxygenation: Heparin versus bivalirudin.
Kartika T; Mathews R; Migneco G; Bundy T; Kaempf AJ; Pfeffer M; DeLoughery TG; Moore K; Beardshear R; Oetken HJ; Case J; Hinds MT; McCarty OJT; Shatzel JJ; Zonies D; Zakhary B
Eur J Haematol; 2024 Apr; 112(4):566-576. PubMed ID: 38088062
[TBL] [Abstract][Full Text] [Related]
2. Comparison of bivalirudin versus heparin in adult extracorporeal membrane oxygenation anticoagulant therapy: A retrospective case-control study.
Tong Y; Rouzhahong J; Zhou W; Wang R; Wang Y; Ren Y; Guo J; Li Y; Wang Z; Song Y
Int J Artif Organs; 2023 Mar; 46(3):162-170. PubMed ID: 36600413
[TBL] [Abstract][Full Text] [Related]
3. Comparison of Anticoagulation Strategies in Patients Requiring Venovenous Extracorporeal Membrane Oxygenation: Heparin Versus Bivalirudin.
Rivosecchi RM; Arakelians AR; Ryan J; Murray H; Ramanan R; Gomez H; Phillips D; Sciortino C; Arlia P; Freeman D; Sappington PL; Sanchez PG
Crit Care Med; 2021 Jul; 49(7):1129-1136. PubMed ID: 33711003
[TBL] [Abstract][Full Text] [Related]
4. Bivalirudin versus heparin anticoagulation in patients receiving extracorporeal membrane oxygenation.
Huang D; Guan Q; Qin J; Shan R; Wu J; Zhang C
Perfusion; 2023 Sep; 38(6):1133-1141. PubMed ID: 35616224
[TBL] [Abstract][Full Text] [Related]
5. Heparin-Sparing Anticoagulation Strategies Are Viable Options for Patients on Veno-Venous ECMO.
Carter KT; Kutcher ME; Shake JG; Panos AL; Cochran RP; Creswell LL; Copeland H
J Surg Res; 2019 Nov; 243():399-409. PubMed ID: 31277018
[TBL] [Abstract][Full Text] [Related]
6. Is bivalirudin an alternative anticoagulant for extracorporeal membrane oxygenation (ECMO) patients? A systematic review and meta-analysis.
Li DH; Sun MW; Zhang JC; Zhang C; Deng L; Jiang H
Thromb Res; 2022 Feb; 210():53-62. PubMed ID: 35007937
[TBL] [Abstract][Full Text] [Related]
7. Heparin-based versus bivalirudin-based anticoagulation in pediatric extracorporeal membrane oxygenation: A systematic review.
Valdes CA; Sharaf OM; Bleiweis MS; Jacobs JP; Mumtaz M; Sharaf RM; Jeng EI; Peek GJ
Front Med (Lausanne); 2023; 10():1137134. PubMed ID: 36999064
[TBL] [Abstract][Full Text] [Related]
8. Anticoagulation strategies in COVID-19 infected patients receiving ECMO support.
Diaz D; Martinez J; Bushman G; Wolowich WR
J Extra Corpor Technol; 2023 Sep; 55(3):121-129. PubMed ID: 37682210
[TBL] [Abstract][Full Text] [Related]
9. Extracorporeal Membrane Oxygenation Complications in Heparin- and Bivalirudin-Treated Patients.
Giuliano K; Bigelow BF; Etchill EW; Velez AK; Ong CS; Choi CW; Bush E; Cho SM; Whitman GJR
Crit Care Explor; 2021 Jul; 3(7):e0485. PubMed ID: 34278315
[TBL] [Abstract][Full Text] [Related]
10. Use of bivalirudin for anticoagulation in pediatric extracorporeal membrane oxygenation (ECMO).
Kaushik S; Derespina KR; Chandhoke S; Shah DD; Cohen T; Shlomovich M; Medar SS; Peek GJ
Perfusion; 2023 Jan; 38(1):58-65. PubMed ID: 34318718
[TBL] [Abstract][Full Text] [Related]
11. Analysis of Wholesale Drug Acquisition and Laboratory Assessment Costs Between Heparin Compared With Bivalirudin-Based Systemic Anticoagulation Strategies in Adult Extracorporeal Membrane Oxygenation.
Seelhammer TG; Brokmeier HM; Hamzah M; Wieruszewski PM
Crit Care Med; 2023 May; 51(5):e115-e121. PubMed ID: 36853326
[TBL] [Abstract][Full Text] [Related]
12. Bivalirudin or heparin for systemic anticoagulation during pediatric extracorporeal membrane oxygenation: Multicenter retrospective study.
Hamzah M; Seelhammer TG; Beshish AG; Byrnes J; Yabrodi M; Szadkowski A; Lutfi R; Andrijasevic N; Hock K; Worley S; Macrae DJ
Thromb Res; 2023 Sep; 229():178-186. PubMed ID: 37517208
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of Bivalirudin As an Alternative to Heparin for Systemic Anticoagulation in Pediatric Extracorporeal Membrane Oxygenation.
Hamzah M; Jarden AM; Ezetendu C; Stewart R
Pediatr Crit Care Med; 2020 Sep; 21(9):827-834. PubMed ID: 32404633
[TBL] [Abstract][Full Text] [Related]
14. Bivalirudin Versus Unfractionated Heparin in Patients With Cardiogenic Shock Requiring Venoarterial Extracorporeal Membrane Oxygenation.
Uricchio MN; Ramanan R; Esper SA; Murray H; Kaczorowski DJ; D'Aloiso B; Gomez H; Sciortino C; Sanchez PG; Sappington PL; Rivosecchi RM
ASAIO J; 2023 Jan; 69(1):107-113. PubMed ID: 35412480
[TBL] [Abstract][Full Text] [Related]
15. Venovenous Extracorporeal Membrane Oxygenation With Prophylactic Subcutaneous Anticoagulation Only: An Observational Study in More Than 60 Patients.
Krueger K; Schmutz A; Zieger B; Kalbhenn J
Artif Organs; 2017 Feb; 41(2):186-192. PubMed ID: 27256966
[TBL] [Abstract][Full Text] [Related]
16. Heparin Versus Bivalirudin for Anticoagulation in Adult Extracorporeal Membrane Oxygenation: A Systematic Review and Meta-Analysis.
Wieruszewski PM; Macielak SA; Nei SD; Moman RN; Seelhammer TG; Nabzdyk CGS; Gerberi DJ; Mara KC; Hooten WM; Wittwer ED
ASAIO J; 2023 Feb; 69(2):137-144. PubMed ID: 36355803
[TBL] [Abstract][Full Text] [Related]
17. Superiority of bivalirudin over heparin anticoagulation therapy for extracorporeal membrane oxygenation? Too early to draw conclusions.
Gu J; Yu H; Lin D
Heliyon; 2023 Feb; 9(2):e13530. PubMed ID: 36865472
[TBL] [Abstract][Full Text] [Related]
18. Bivalirudin May Reduce the Need for Red Blood Cell Transfusion in Pediatric Cardiac Patients on Extracorporeal Membrane Oxygenation.
Machado DS; Garvan C; Philip J; Harrington D; Spiess B; Kelly B; Campbell CT; Pelletier JPR; Islam S; Peek GJ; Bleiweis MS
ASAIO J; 2021 Jun; 67(6):688-696. PubMed ID: 33031157
[TBL] [Abstract][Full Text] [Related]
19. Heparin vs bivalirudin anticoagulation for extracorporeal membrane oxygenation.
Kaseer H; Soto-Arenall M; Sanghavi D; Moss J; Ratzlaff R; Pham S; Guru P
J Card Surg; 2020 Apr; 35(4):779-786. PubMed ID: 32048330
[TBL] [Abstract][Full Text] [Related]
20. Bivalirudin-based versus conventional heparin anticoagulation for postcardiotomy extracorporeal membrane oxygenation.
Ranucci M; Ballotta A; Kandil H; Isgrò G; Carlucci C; Baryshnikova E; Pistuddi V;
Crit Care; 2011; 15(6):R275. PubMed ID: 22099212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
